PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Multiple Sclerosis Clinical and Research Unit, Department of Systems Medicine, Tor Vergata University, Rome, Italy. Electronic address: doriana.landi@gmail.com.\', \'Multiple Sclerosis Clinical and Research Unit, Department of Systems Medicine, Tor Vergata University, Rome, Italy. Electronic address: carolgabri@gmail.com.\', \'Multiple Sclerosis Clinical and Research Unit, Department of Systems Medicine, Tor Vergata University, Rome, Italy. Electronic address: giovannidimauro92@gmail.com.\', \'Multiple Sclerosis Clinical and Research Unit, Department of Systems Medicine, Tor Vergata University, Rome, Italy. Electronic address: colagaia@gmail.com.\', \'Multiple Sclerosis Clinical and Research Unit, Department of Systems Medicine, Tor Vergata University, Rome, Italy. Electronic address: alfonso.grimaldi@uniroma2.it.\', \'Multiple Sclerosis Clinical and Research Unit, Department of Systems Medicine, Tor Vergata University, Rome, Italy. Electronic address: giorgia.mataluni@gmail.com.\', \'Multiple Sclerosis Clinical and Research Unit, Department of Systems Medicine, Tor Vergata University, Rome, Italy; Unit of Neurology, IRCCS Neuromed, Pozzilli (IS), Italy. Electronic address: marfia@uniroma2.it.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S2211-0348(21)00601-510.1016/j.msard.2021.103334
?:hasPublicationType
?:journal
  • Multiple sclerosis and related disorders
is ?:pmid of
?:pmid
?:pmid
  • 35158447
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.123
?:rankingScore_hIndex
  • 18
is ?:relation_isRelatedTo_publication of
?:title
  • Anti-HBs titers are not decreased after treatment with oral Cladribine in patients with Multiple Sclerosis vaccinated against Hepatitis B virus.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all